Optimizing diet for patients with ulcerative colitis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical intervention involves patients with moderately active ulcerative colitis who are randomized into two groups: one following a normal healthy diet and the other eliminating emulsifying agents such as carrageenan, CMC, and polysorbates. The study will analyze dietary habits, clinical characteristics, and microbiota before and after a one-month intervention. Key measurements will include disease activity assessed through calprotectin levels and microbiota diversity. The goal is to determine if dietary modifications can lead to improvements in disease symptoms and microbiota composition.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Ulcerative colitis,
* Moderately active
* Stable medication

Exclusion Criteria:

* Severe disease
* Recent surgery
* Proctitis
* Pregancy
* Treatment with antibiotics
* Difficulties in understanding the information about the study
* Multimorbidity that makes it impossible to participate

Where it's running

• Region Skåne
  Malmö, Skåne County, Sweden Recruiting

Study contacts

• Principal investigator: Klas Sjöberg, Prof — Dept of Gastroenterology, SUS, Malmö, Sweden
• Study coordinator: Klas Sjöberg, Prof
• Email: klas.sjoberg@med.lu.se
• Phone: +46702372580

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Personalized dietary responses for better health

  This study is testing how different foods affect people's health based on their unique responses, and it's for individuals taking part in the ZOE testing program.

  Recruiting at 2 sites Zoe Global Limited · Needham, Massachusetts and 1 other locations · NCT04735835

• Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy

  This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.

  Recruiting at 5 sites Austin Health · Hobart and 6 other locations · NCT07916727

• A Probiotic Approach to Modulating Gut Microbiota in Mild-to-Moderate Ulcerative Colitis

  A specific probiotic given rectally will be tested in adults with mild-to-moderate ulcerative colitis to see if it can help manage symptoms.

  Recruiting Catholic University of the Sacred Heart · Roma, RM · NCT07724990

• Advanced therapies for moderately to severely active Crohn's disease or ulcerative colitis in adults

  This study tests combinations of risankizumab with either trosunilimab or ABBV-701 in adults with moderately to severely active Crohn's disease or ulcerative colitis.

  Recruiting at 66 sites Phase 2 AbbVie · Dothan, Alabama and 65 other locations · NCT07697456

• Longitudinal Immunophenotyping of People with Inflammatory Bowel Disease

  This study will follow adults with Crohn's disease or ulcerative colitis (and some healthy relatives) over three years to see how their immune cells change over time and how genetics and diet relate to their disease.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07619547

• Trying a mostly plant-based diet for adults in Singapore with stage 3–4 chronic kidney disease

  This two-year outpatient study will try a mostly plant-based diet—at least 50% of protein from plants—in adults with stage 3–4 CKD to see if it is practical, safe (especially for potassium), and helpful compared with standard CKD diet advice.

  Recruiting Changi General Hospital · Singapore · NCT07544524

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.